It develops its products through cellular regeneration, gene therapy, and precision medicine platforms. The company is developing TN-201, an adeno- ...
https://www.google.com/url?rct=j&sa=t&url=https://www.defenseworld.net/2022/08/21/tenaya-therapeutics-inc-nasdaqtnya-shares-purchased-by-new-york-state-common-retirement-fund.html&ct=ga&cd=CAIyGmEyNDJjNTAxZWU3OTQyNzI6Y29tOmVuOlVT&usg=AOvVaw1x7U8qoOOQtRshgtE5Hh_j
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.